Bio-Techne (TECH) Total Current Liabilities (2010 - 2026)

Bio-Techne's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $153.3 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 9.41% year-over-year to $153.3 million; the TTM figure through Mar 2026 stood at $153.3 million (down 9.41% YoY), while the FY2025 annual figure was $175.8 million, up 10.33% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $153.3 million, up from $140.4 million in the prior quarter.
• The five-year high for Total Current Liabilities was $176.0 million in Q2 2022, with the low at $127.8 million in Q3 2023.
• The 5-year median for Total Current Liabilities is $144.5 million (2025), against an average of $149.3 million.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities dropped 26.99% in 2023, then rose 24.02% in 2024.
• Bio-Techne's Total Current Liabilities stood at $128.4 million in 2022, then rose by 5.32% to $135.2 million in 2023, then grew by 19.24% to $161.3 million in 2024, then fell by 12.92% to $140.4 million in 2025, then gained by 9.15% to $153.3 million in 2026.
• Business Quant data shows TECH's Total Current Liabilities at $153.3 million in Q1 2026, $140.4 million in Q4 2025, and $144.5 million in Q3 2025.